Fundraising Fox

Kolon TissueGene

Rockville, US · Delaware corporation

Biotech

Founders & leadership

CS
Charles Stephen NyeNamed on SEC filing
SJ
Sun Jin KimNamed on SEC filing
YJ
Yonggyun JeongNamed on SEC filing
SS
Sung Su HanNamed on SEC filing
GY
Gun Young ParkNamed on SEC filing
MJ
Moon Jong NohNamed on SEC filing
JI
Jung In KimNamed on SEC filing
SK
Soon-Wook KweonNamed on SEC filing
DH
Diana HalimNamed on SEC filing
SJ
Sun Joo LeeNamed on SEC filing
YJ
Young Joon KimNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$124.7M disclosed across 4 rounds · 2021–2024

▶$35MraisedJun 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Soon-Wook KweonExecutive Officer
  • Yonggyun JeongExecutive Officer
  • Gun Young ParkExecutive Officer
  • Sun Jin KimExecutive Officer
  • Jung In KimExecutive Officer, Director
  • Sun Joo LeeDirector
  • Charles NyeExecutive Officer
  • Young Joon KimExecutive Officer
  • Diana HalimExecutive Officer
  • Moon Jong NohExecutive Officer, Director
Offering amount
$35M
Amount sold
$35M
First sale
May 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30MraisedMay 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles Stephen NyeExecutive Officer
  • Sun Jin KimExecutive Officer
  • Yonggyun JeongExecutive Officer
  • Sung Su HanExecutive Officer, Director
  • Gun Young ParkExecutive Officer
  • Moon Jong NohExecutive Officer, Director
  • Jung In KimExecutive Officer, Director
  • Soon-Wook KweonExecutive Officer
  • Diana HalimExecutive Officer
  • Sun Joo LeeDirector
  • Young Joon KimExecutive Officer
Offering amount
$30M
Amount sold
$30M
First sale
May 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$29.6MraisedAug 2022 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jangik LeeDirector
  • Charles Stephen NyeExecutive Officer
  • Young Joon KimExecutive Officer
  • Moon Jong NohExecutive Officer, Director
  • Sun Jin KimExecutive Officer
  • Sung Su HanExecutive Officer, Director
  • Soon-Wook KweonExecutive Officer
  • Yonggyun JeongExecutive Officer
  • Jung In KimExecutive Officer, Director
Offering amount
$29.6M
Amount sold
$29.6M
First sale
Aug 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30.1MraisedDec 2021 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sun Jin KimExecutive Officer
  • Yonggyun JeongExecutive Officer
  • Young Joon KimExecutive Officer
  • Jangik LeeDirector
  • Min Seok KimExecutive Officer, Director
  • Moon Jong NohExecutive Officer, Director
  • Sung Su HanExecutive Officer, Director
  • Charles Stephen NyeExecutive Officer
  • Soon-Wook KweonExecutive Officer
Offering amount
$30.1M
Amount sold
$30.1M
First sale
Dec 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Kolon TissueGene raised?
Kolon TissueGene has disclosed $124.7M raised across 4 rounds.
Where is Kolon TissueGene headquartered?
Kolon TissueGene is headquartered in Rockville, US.